Stay updated on Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3 on this ClinicalTrials.gov study page. This represents a minor update to the page metadata.
    Difference
    0.1%
    Check dated 2026-07-11T04:40:52.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    The revision label on the page footer updated from v3.6.0 to v3.6.2. This indicates a newer revision of the page record without implying changes to the study content.
    Difference
    0.1%
    Check dated 2026-06-27T02:03:59.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The study record now indicates recruitment is closed (no longer looking for participants); new sections were added to help users read the study record and join a study (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and a revision note for v3.6.0 was added.
    Difference
    0.6%
    Check dated 2026-06-12T14:55:36.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The bottom of the page now shows Revision: v3.5.5, replacing v3.5.4, indicating a small page update rather than a substantive change to the study record.
    Difference
    0.1%
    Check dated 2026-06-05T10:37:12.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page now shows a new revision label v3.5.4, replacing the previous v3.5.3. This indicates a minor release or update marker rather than a change to study data or content.
    Difference
    0.1%
    Check dated 2026-05-15T04:45:35.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.5.3 was added and Revision: v3.5.2 was removed, reflecting a small update to the page’s version history. It indicates an administrative update rather than a substantive change to study details.
    Difference
    0.1%
    Check dated 2026-04-30T18:53:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page.